gabexate has been researched along with Bone Loss, Osteoclastic in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bone metastases from gastric cancer (GC) are considered a relatively uncommon finding; however, they are related to poorer prognosis." | 2.52 | Targeting mast cells in gastric cancer with special reference to bone metastases. ( Ammendola, M; De Sarro, G; Gadaleta, CD; Leporini, C; Marech, I; Oakley, C; Ranieri, G; Russo, E; Sacco, R; Sammarco, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leporini, C | 1 |
| Ammendola, M | 1 |
| Marech, I | 1 |
| Sammarco, G | 1 |
| Sacco, R | 1 |
| Gadaleta, CD | 1 |
| Oakley, C | 1 |
| Russo, E | 1 |
| De Sarro, G | 1 |
| Ranieri, G | 1 |
1 review available for gabexate and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Targeting mast cells in gastric cancer with special reference to bone metastases.
Topics: Animals; Antigens, CD34; Benzamides; Benzamidines; Bone and Bones; Bone Neoplasms; Bone Resorption; | 2015 |